https://www.selleckchem.com/products/alc-0159.html
Background A recent consensus statement introduced the term "ET plus". Although investigators have quantified the prevalence of ET plus in cross-sectional studies, patients with ET plus have not been tracked longitudinally; hence, there is no understanding of its stability over time. Methods We present prospective, longitudinal phenotypic data on an ET cohort that was followed regularly at 18-month intervals (T1, T2, T3, T4) for up to 64 months. We assigned an ET or ET plus diagnosis to each case at each time interval. Results There we
Curtir
Comentario
Compartilhar
